Getting latest data loading
Home / Movers & Shakers / Movers & Shakers

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Movers & Shakers - 8 November 2018

The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited

AstraZeneca Q3 revenues $5.34B beats $5.31B consensus (product sales +8% boosted by new medicines and emerging markets); core operating profit $1.32B beats $1.15B est; Core EPS 71c beats 65c est; Backs FY 2018 Product Sales and Core EPS guidance.

Sainsbury H1 underlying pre-tax profit £302M (+20.3%) beats £278M consensus; Underlying group sales +0.6% like-for-like (Q2 1% vs Q1 0.2%); Q2 Grocery stronger, Gen Merch slower, Clothing negative; Argos synergy target hit early; Net debt -40% = temp; Backs FY guidance (£643M underlying pre-tax); consumer outlook uncertain, all areas highly competitive and very promotional.

Burberry H1 like-for-like revenue -2% YoY (+4% ex-Beauty wholesale on strength of Asia travel retail), adj. op. profit +8%, free cash flow -73%, divi unchanged, FY guidance reiterated incl. £100m in cumulative cost savings.

National Grid H1 underlying op. profit -6% YoY (Electricity +3%, Gas -37%, US -17%, NG +31%.), underlying pre-tax profit -4%, capex +7%, interim div +3.8%. UK business on track to outperform by 200-300 bps, sees 7%+ asset growth in next 2 years and at top of 5-7% range in med-term.

Hikma Pharmaceuticals raises FY guidance after profitability improved more than expectations. Injectables rev. now expected $825-850m (39-40% margin), Generics rev. now expected $675-700m (low teens margin). Branded FY guidance unchanged in mid-single digits growth. Agrees with Vectura to global development/commercialisation of generic versions of GSK’s Ellipta.

(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)


 

For more information on any of these individual news items, call into the trading floor

Prior day's Movers & Shakers:

Stock Code Close High Low
MARKS & SPENCER MKS 1.1% 5.8% -3.2%
ITV ITV -3.1% -2.9% -5.9%
PERSIMMON PSN -0.2% 1.1% -1.6%
WIZZ AIR WIZZ 10.4% 10.8% -6.4%
WETHERSPOON JDW -11.8% -2.3% -13.0%
Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Prepared by Michael van Dulken, Head of Research
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.